IBIO SCHEDULE 13G/A: SEC filing

A Schedule 13G/A amendment was

Filed with the SEC on Aug 14, 2026 · accession 0001172661-26-003690

IBIO filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Aug 14, 2026. A report the company filed with the SEC (the US market regulator). The stock moved +2.1% by the first close after the filing.

Summary of the filing

A Schedule 13G/A amendment was filed regarding beneficial ownership of iBio, Inc. common stock, indicating a change in a holder's passive ownership position.

For details, click here →

Key details

IssueriBio, Inc.

How IBIO stock reacted

Close before

$1.40

Aug 13, 2026

First close after

+2.14%

$1.43

5 trading days

+5.00%

$1.47

Since filing

-47.24%

$0.74

✦ Ask GOAX AI about this filing — what it means for IBIO, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for IBIO?

Click here

Frequently asked questions

What did IBIO file with the SEC on Aug 14, 2026?

IBIO filed a SCHEDULE 13G/A (SEC filing). A Schedule 13G/A amendment was filed regarding beneficial ownership of iBio, Inc. common stock, indicating a change in a holder's passive ownership position.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did IBIO stock react to this filing?

IBIO closed at $1.40 before the filing and $1.43 on Aug 14, 2026 (+2.14%). Five trading days later: $1.47 (+5.00%).

Other IBIO SEC filings

Get alerts when IBIO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

IBIO overview IBIO analysis IBIO news Latest SEC filings